Scientist awarded for breakthrough RNA research that led to Spinraza
A New York-based scientist has been awarded for his pioneering work that led to the development of Spinraza (nusinersen), the first RNA-based therapy to target the underlying cause of spinal muscular atrophy (SMA). Adrian R. Krainer, PhD, a professor at Cold Spring Harbor Laboratory, in New York, will formally…